by Patrick Devlin
The Drug Enforcement Administration has determined again that cannabis has “no currently accepted medical use and (has) a high potential for abuse.”
The federal agency that is under the direction of the office of the president has determined that cannabis is among the “most dangerous drugs” and threatens users with “potentially severe psychological or physical dependence.”
The DEA confirmed their belief that cannabis is as great a danger to the public as heroin,
lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
The DEA said in a letter that their decision was “based on whether marijuana, as determined by the FDA, is a safe and effective medicine,” he said, “and it’s not.” The letter went on to say that it “would be a wonderful and welcome development” if it could be scientifically proven that cannabis is an effective medicine, “but we insist that CBD research, or any research, be sound, scientific, and rigorous before a product can be authorized for medical use.”
President Obama has stated that he wants the decision to re-schedule cannabis to be driven by science rather than ideology, but critics point to the fact that the DEA’s own aggressive scheduling of cannabis itself stifles research into the medically important substance.
The regulatory dilemma that exists; where cannabis is deemed too dangerous to research by regulators and deemed not scientifically studied enough to be medicine by law enforcers, has led to a stalemate that has thwarted the advancement of science to the peril and ill health of sick patients.
Forty-two states have passed laws allowing their citizens to use medical cannabis.